Skip to main content

Table 1 Artemisin-containing oral pharmaceutical products obtained from registered pharmacies in Dar-es-Salaam, Tanzania, 2005

From: Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam

Product/active ingredient(s)

Formulation

Country of origin*

2005 availability

(n = 29)

Named in the top 3 sellers

in 2005 (n = 28)

Mean selling

price 2005

1. artemether/lumefantrine

20/120 mg tablets, co-formulated

Switzerland

21 (72.4%)

5 (17.9%)

$ 7.59

2. artesunate and mefloquine

200 mg and 250 mg tablets, co-packaged

Switzerland

17 (58.6%)

0

$ 7.05

3. artesunate

50 mg tablets

China

6 (20.7%)

0

$ 4.62

4. artesunate

50 mg tablets

France

24 (82.8%)

7 (25.0%)

$ 5.48

5. artesunate

50 mg tablets

Switzerland

8 (27.6%)

0

$ 5.26

6. artesunate

50 mg tablets

Belgium

28 (96.6%)

3 (10.7%)

$ 3.53

7. artesunate

50 mg tablets

India

17 (58.6%)

0

$ 2.51

8. artesunate

100 mg tablets

Belgium

28 (96.6%)

28 (100%)

$ 4.99

9. artesunate

100 mg tablets

Tanzania

7 (24.1%)

1 (3.6%)

$ 2.19

10. artesunate

100 mg tablets

Tanzania

20 (69.0%)

6 (21.4%)

$ 1.92

11. artesunate

100 mg tablets

Kenya

2 (6.9%)

0

$ 2.31

12. artesunate

200 mg tablets

Switzerland

19 (65.5%)

1 (3.6%)

$ 6.72

13. artemether

40 mg tablets

India

8 (27.6% 0

0

$ 2.24

14. artemether

50 mg tablets

China

24 (82.8%)

15 (53.6%)

$ 4.74

15. artemether

180 mg/60 ml suspension

Belgium

18 (62.1%)

0

$ 4.65

16. artemether

300 mg/100 ml suspension

Belgium

3 (10.3%)

0

$ 5.75

17. dihydroartemisinin

60 mg tablets

Korea

18 (62.1%)

0

$ 4.36

18. dihydroartemisinin

60 mg tablets

China

25 (86.2%)

9 (35.7%)

$ 4.55

19. dihydroartemisinin

160 mg/80 ml suspension

China

20 (69.0%)

0

$ 4.18

  1. *Country of origin refers to the address of the company holding registration for this product in Tanzania (with the exception of product 11 which was not registered in the country). In some cases drugs that are produced in Asia are packaged and distributed by pharmaceutical partners in Africa and Europe. This information was not consistently provided.
  2. On 15 July 2005 = US $1.00 = 1188 Tanzania shillings